Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins
Intracellular, Secreted (different isoforms)
Cell type enhanced (Hepatocytes, Alveolar cells type 2, Alveolar cells type 1, Gastric mucus-secreting cells)
Not detected in immune cells
Cell line enhanced (A-431, CACO-2, HaCaT, HeLa, RPTEC TERT1)
Monomer. Can self-associate to form dimers and higher multimers which may have increased LDLR degrading activity. The precursor protein but not the mature protein may form multimers. Interacts with APOB, VLDLR, LRP8/APOER2 and BACE1. The full-length immature form (pro-PCSK9) interacts with SCNN1A, SCNN1B and SCNN1G. The pro-PCSK9 form (via C-terminal domain) interacts with LDLR. Interacts (via the C-terminal domain) with ANXA2 (via repeat Annexin 1); the interaction inhibits the degradation of LDLR (PubMed:18799458).
Hydrolase, Protease, Serine protease
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.